期刊文献+

米力农联合多巴酚丁胺早期治疗儿童重症手足口病的疗效观察 被引量:4

Clinical observation on children's severe hand-foot-mouth disease treated by milrinone combining with dobutamine
下载PDF
导出
摘要 目的观察米力农联合多巴酚丁胺早期治疗重症手足口病的临床疗效。方法将76例重症手足口病患儿随机分为四组。将患儿进行临床分期,观察并分析临床疗效。结果对照组9例进展到心肺功能衰竭前期,4例并发心肺功能衰竭,死亡3例,米力农组及多巴酚丁胺组各6例进展到心肺功能衰竭前期,2例并发心肺功能衰竭,死亡1例;米力农联合多巴酚丁胺组1例进展到心肺功能衰竭前期,无死亡病例。米力农+多巴酚丁胺组平均住院日为(9.53±2.12)d,明显低于其余各组(<0.05)。呼吸机撤机时间米力农+多巴酚丁胺组明显少于其余各组(<0.05),为(5.5±0.71)d。心肌酶恢复时间米力农联合多巴酚丁胺组与其他组相比无统计学意义(>0.05)。结论米力农联合多巴酚丁胺早期治疗重症手足口病能明显改善心肺功能,减少神经源性肺水肿及呼吸循环衰竭的发生率,改善预后及缩短治疗时间。 Objective To investigate clinical effects on children's severe hand-foot-mouth disease treated by milrinone combining with dobutamine.Methods 76 cases of severe hand-foot-mouth disease patients were randomly divided into four group,and implement clinical stages were further carried out to observe and analyse the clinical effects.Results In the control group,9 cases developed to the prophase cardiorespiratory failure,among of which 4 cases developed to cardiorespiratory failure,and 3 cases died,However,in milrinone or dobutamine treated group,6 cases developed to the prophase cardiorespiratory failure,anong of which 2 cases developed to cardiorespiratory failure,and 1 cases died,respectively;While Milrinone combining with dobutamine treated group,only 1 cases developed to the prophase cardiorespiratory failure,and no case died.Furthermore,an average inpatient days in milrinone combining with dobutamine treated group were(9.53±0.89)d,and obviously less than those of the other groups(P〈 0.05).Similarly,breathing machine ventilator weaning time,which were was(5.5±0.71)d,of milrinone combining with dobutamine group were less than those of the other groups(P〉 0.05),Myocardial enzymes recovery time of milrinone combining with dobutamine group was not statistically significant compared with the other groups(P 0.05).Conclusion Early treatments with milrinone combining with dobutamine for severe hand-foot-mouth disease can significantly improve heart function,reduce neurogenic pulmonary edema,the incidence of respiratory and circulatory failure,improve the prognosis and shorten the period of treatment.
出处 《遵义医学院学报》 2011年第5期499-501,共3页 Journal of Zunyi Medical University
关键词 手足口病 米力农 多巴酚丁胺 hand-foot-mouth disease milrinone dobutamine
  • 相关文献

参考文献11

二级参考文献66

共引文献365

同被引文献55

  • 1赵枫,徐志云,邹良建,梅举.正性肌力药单独或联合应用治疗重症冠脉旁路移植术后低心排的临床研究[J].第二军医大学学报,2005,26(6):707-708. 被引量:6
  • 2边巴卓嘎,益西央宗.小儿高原性心脏病的治疗[J].西藏医药,2006,27(2):1-2. 被引量:7
  • 3陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465. 被引量:845
  • 4徐淑云.中华临床药物学[M].北京:人民卫生出版社,2003.594. 被引量:25
  • 5Shipley J B, Tolman D, Hastillo A, et al. Milrinone: basic and clinical pharmacology and chronic management [J]. Am J Med Sci, 1996,311(6):286-291. 被引量:1
  • 6温晓春,蔡爱东.第二十三届全国儿科药学学术会议论文集[C].中国药学会医院药学专业委员会,2012:148-151. 被引量:1
  • 7Hoffman T M, Wernovsky G, Atz A M, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease [ J ]. Circulation, 2003,107 (7) :996-1002. 被引量:1
  • 8郭宏伟,王武军.特异性磷酸二酯酶抑制剂在风湿性左心瓣膜病肺动脉高压患者围术期的应用研究[C].中国博士学位论文全文数据库,2012:114-115. 被引量:1
  • 9王燕,牛玲,安新江.雾化吸人米力农与硝酸甘油对先天性心脏病患儿继发肺动脉高压效果的比较[C]//江浙沪儿科学术年会暨浙江省医学会儿科学分会学术年会,儿内科疾病诊治新进展国家级学习班论文汇编,2012:480. 被引量:1
  • 10XING W,LIAO Q,VIBOUD C,et al.Hand,foot,andmouth disease in China,2008-12:an epidemiological study[J].Lan- cet Infect Dis,2014,14(4):308-318. 被引量:1

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部